Allianz Asset Management
IRON icon

Allianz Asset Management’s Disc Medicine IRON Stock Holding History

Allianz Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000
Closed -$238K – 2065
2025
Q4 		$238K Buy
+3,000
New +$253K ﹤0.01% 1918

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Allianz Asset Management's IRON Position: Q1 2026 in Review

Allianz Asset Management sold out of Disc Medicine (IRON) in Q1 2026, closing a stake of 3,000 shares — an estimated $238K sold.

Allianz Asset Management first reported a position in IRON in Q4 2025 and held it in 1 quarter. The position peaked at $238K in Q4 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • Allianz Asset Management reported no remaining Disc Medicine position as of Q1 2026 after selling out during the quarter.
  • Allianz Asset Management sold 3,000 Disc Medicine shares in Q1 2026, an estimated $238K.
  • Allianz Asset Management first reported a position in Disc Medicine in Q4 2025 and held it in 1 quarter.
  • Allianz Asset Management's Disc Medicine position peaked at $238K in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.